DE MANZONI, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 11.643
NA - Nord America 9.683
AS - Asia 6.784
SA - Sud America 1.018
AF - Africa 210
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 29.377
Nazione #
US - Stati Uniti d'America 9.500
RU - Federazione Russa 4.704
GB - Regno Unito 2.717
SG - Singapore 2.717
CN - Cina 2.270
IT - Italia 848
BR - Brasile 842
HK - Hong Kong 711
SE - Svezia 635
DE - Germania 623
FR - Francia 582
IE - Irlanda 573
FI - Finlandia 437
VN - Vietnam 338
KR - Corea 232
UA - Ucraina 162
TR - Turchia 103
CA - Canada 91
JP - Giappone 87
NL - Olanda 66
ES - Italia 63
AR - Argentina 60
MX - Messico 55
AT - Austria 53
IN - India 52
TG - Togo 48
ID - Indonesia 46
BE - Belgio 38
BJ - Benin 38
BD - Bangladesh 37
ZA - Sudafrica 36
PL - Polonia 35
EC - Ecuador 34
IQ - Iraq 24
PY - Paraguay 24
AU - Australia 22
RW - Ruanda 21
CZ - Repubblica Ceca 19
IL - Israele 18
PK - Pakistan 17
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 16
IR - Iran 15
LT - Lituania 15
CO - Colombia 14
CL - Cile 13
MA - Marocco 13
JO - Giordania 11
KG - Kirghizistan 11
VE - Venezuela 11
PT - Portogallo 10
EG - Egitto 9
EU - Europa 9
UY - Uruguay 9
NO - Norvegia 8
PE - Perù 8
SA - Arabia Saudita 8
TN - Tunisia 8
KE - Kenya 7
LV - Lettonia 7
PA - Panama 7
AO - Angola 6
BG - Bulgaria 6
HN - Honduras 6
TW - Taiwan 6
DZ - Algeria 5
GR - Grecia 5
JM - Giamaica 5
OM - Oman 5
PH - Filippine 5
AL - Albania 4
AZ - Azerbaigian 4
CH - Svizzera 4
KZ - Kazakistan 4
MK - Macedonia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BZ - Belize 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
LK - Sri Lanka 3
SI - Slovenia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CM - Camerun 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
HR - Croazia 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
Totale 29.337
Città #
Southend 2.395
Moscow 1.508
Jacksonville 1.154
Chandler 1.142
Singapore 1.094
Dallas 967
Hong Kong 710
Ashburn 707
Woodbridge 699
Dublin 568
Ann Arbor 460
Beijing 414
Verona 356
Houston 317
New York 244
The Dalles 208
Lawrence 204
Los Angeles 204
Princeton 204
Wilmington 199
Jinan 182
Nanjing 154
Munich 141
Shenyang 140
Ho Chi Minh City 133
Redmond 132
Buffalo 106
Hebei 100
Helsinki 99
Milan 97
Sindelfingen 97
Redondo Beach 80
Tokyo 78
Columbus 76
London 71
São Paulo 71
Changsha 69
Hanoi 69
Tianjin 66
Nanchang 62
Santa Clara 60
Seoul 60
Haikou 56
Zhengzhou 55
Seattle 49
Jiaxing 48
Lomé 48
Guangzhou 47
Ningbo 47
Boardman 43
Amsterdam 42
Taizhou 39
Brussels 38
Cotonou 38
Hangzhou 38
Turku 36
Nuremberg 33
Atlanta 32
Council Bluffs 32
San Francisco 32
Vienna 32
Brooklyn 30
Chicago 30
Dearborn 30
Stockholm 30
Warsaw 29
Denver 28
Montreal 28
Norwalk 28
Rio de Janeiro 27
Rome 26
Frankfurt am Main 24
Madrid 24
Boston 23
Phoenix 23
Johannesburg 22
Taiyuan 22
Dong Ket 21
Fuzhou 21
Jakarta 21
Kigali 21
Redwood City 21
Toronto 21
Lanzhou 20
Washington 19
Belo Horizonte 18
Curitiba 18
Falls Church 18
Lappeenranta 18
Mexico City 18
Poplar 17
Chennai 16
Fairfield 15
Manchester 15
Orem 15
Tashkent 15
Ankara 14
Falkenstein 14
Dongguan 13
Guayaquil 13
Totale 17.508
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 285
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 270
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 255
[Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. 229
Genomic characterization of hepatoid tumors: context matters 227
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 223
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 206
Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years 197
[Advanced gastric adenocarcinoma with RER+ phenotype presents a good prognosis after 5 years of curative resection] 183
ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer 182
Adenocarcinoma of the esophagogastric junction 182
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study 181
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 181
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 178
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. 175
Acute hemorrhage secondary to gastric ulcer. Results of emergency endoscopic treatment in 775 cases. 175
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 174
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker 173
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 172
Emergency sclerotherapy in esophageal and gastric acutely variceal bleeding : ten years expérience (1988-1997). 166
Enhanced recovery protocol in esophagectomy, is it really worth it? A cost analysis related to team experience and protocol compliance 164
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 164
Valutazione dell’applicabilità del modello organizzativo della weeksurgery alle Chirurgia Generale di un Presidio di un’AziendaOspedaliera del Veneto 163
Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients 161
hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications. 160
Pediatric Palliative Care: Historical Origins and a Glimpse into Ethical Issues 159
Via biliare principale, pancreatite acuta e chirurgia mini-invasiva. 159
Valutazione di uno screening colonscopico in pazienti ad alto rischio di CRC 158
Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. 156
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 156
Changing clinical and pathological features of gastric cancer over time. 156
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 156
Clinical pathways in gastric cancer care 155
Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction 154
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 152
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 149
Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci 149
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 148
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 148
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 147
Authors' reply: Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci (letter) 146
Microsatellite instability in gastric cancer is associated with better prognosis only in stage II cancers 145
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 145
A new way to experience the International Gastric Cancer Association congress: the Web Round Tables 144
Textbook outcome following oesophagectomy for cancer: international cohort study 142
Endoscopic submucosal dissection in the treatment of gastric submucosal tumors: results from a retrospective cohort study. 142
Short-term and long-term risk factors in gastric cancer 142
Lymphadenectomy for gastric cancer at European specialist centres 142
Lack of an association between circulating adiponectin levels and risk of colorectal adenoma. 141
Experience on complex incisional hernia treatment in septic patients 141
Western strategy for EGJ carcinoma 140
Surgical treatment of gastric cancer with coexistent abdominal aortic aneurysm. Personal experience and literature review 139
[Patterns of transition between lymphangioma and intestinal lymphangiectasia. RAdiologic and histologic aspects of 2 cases with predominant involvement of the colon]. 139
Effectiveness of endoscopic vacuum therapy as rescue treatment in refractory leaks after gastro-esophageal surgery 139
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 139
Management of critically ill surgical patients Case reports 138
Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer 137
Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center. 137
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 137
Enhanced Recovery After Surgery can Improve Patient Outcomes and Reduce Hospital Cost of Gastrectomy for Cancer in the West: A Propensity-Score-Based Analysis 137
Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study 136
Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases 135
[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up] 134
Complications after gastrectomy for cancer: Italian perspective 134
Perigastric lymph node metastasis in gastric cancer: comparison between different staging systems 133
Perianal Paget's disease: presentation of six cases and literature review. 133
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer 133
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 131
The value of in vitro ultrasonography in the intraoperative staging of gastric cancer. Blind study of 93 cases. 131
Biomarkers of myocardial infarction in patients undergoing gastrointestinal cancer surgery 131
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 130
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 130
Iatrogenic axillary artery injury from humeral neck fracture repair. A rare and unusual event in which and aggressive strategy was mandatory to save a child limb 129
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 129
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study 129
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience 128
Factors influencing survival after hepatectomy for metastases from gastric cancer 128
Effect of Pyloroplasty on Gastric Conduit Emptying and Patients' Quality of Life After Ivor Lewis Esophagectomy 128
Strengths and Limitations of the Evidence-Based Movement Aimed to Improve Clinical Outcomes in Dentistry and Oral Surgery 127
Staging and treatment of gastric cancer 126
Endosonography in esophageal cancer staging after preoperative chemo and radiotherapy. 126
Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? 125
Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging (letter) 125
Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer 125
Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG) 125
Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus:impact of increased dosage on long-term results 124
Diagnosi precoce del cancro polmonare centrale e periferico in una popolazione ad alto rischio: il progetto S.T.O.P. (Studio Tumori Operabili Polmonari 123
Lymphadenectomy: how to do it? 123
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 123
Preliminary Experience with Prophylactic Thoracic Endovascular Aortic Repair in Patients Affected by Advanced Esophageal Cancer 123
Induction chemio-radiotherapy for squamous cell carcinoma of the thoracic esophagus: long-term results of a phase 2 study 122
Proximal Gastrectomy: Technical Notes 122
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 122
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 121
Utility of Abdominal Drain in Gastrectomy (ADiGe) Trial: study protocol for a multicenter non-inferiority randomized trial 121
Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus 120
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 119
Nodal Staging in Adenocarcinoma of the Gastro-Esophageal Junction. Proposal of a Specific Staging System. Ann Surg Oncol. 119
Lymphatic spread, lymph node stations, and levels of lymphatic dissection in gastric cancer 119
Number of lymph node metastases and its prognostic significance in early gastric cancer: A multicenter italian. study. 118
Totale 15.000
Categoria #
all - tutte 105.120
article - articoli 94.091
book - libri 1.425
conference - conferenze 5.694
curatela - curatele 0
other - altro 586
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.324
Totale 210.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021842 0 0 0 0 0 195 42 120 123 95 208 59
2021/20221.520 93 382 37 129 83 39 40 111 53 53 121 379
2022/20233.544 242 310 327 622 297 867 14 255 384 27 88 111
2023/20242.015 58 167 170 254 219 321 108 110 25 121 351 111
2024/20255.487 295 333 273 846 267 183 400 291 747 439 405 1.008
2025/20269.315 1.090 743 969 2.507 3.893 113 0 0 0 0 0 0
Totale 29.699